2013 Annual Meeting | Child Neurology I
08:00 AM - 08:05 AM |
Introduction
Jonathan W. Mink, MD, PhD, FAAN |
|
08:05 AM - 08:50 AM |
Diagnosis and Management of Brain Injury in the Term and Preterm Newborn
Terrie Inder |
|
08:50 AM - 09:35 AM |
The Epileptic Syndromes and Their Treatment
Howard P. Goodkin, MD, PhD, FAAN |
|
09:35 AM - 10:20 AM |
Neurocutaneous Syndromes
Kevin C. Ess, MD, PhD |
|
10:20 AM - 10:30 AM |
Break
|
|
10:30 AM - 11:15 AM |
Inborn Errors of Metabolism in Child Neurology: A Primer
Marc C. Patterson, MD, FRACP, FAAN |
|
11:15 AM - 12:00 PM |
Neuromuscular Disorders: An Update
Carsten G. Bonnemann, MD |
Jonathan W. Mink, MD, PhD, FAAN | The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS. |
Marc C. Patterson, MD, FRACP, FAAN | Dr. Patterson has received personal compensation for serving as an employee of IntraBio. The institution of Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme /KemPharm/Zevra. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azafaros. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IntraBio. Dr. Patterson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. Dr. Patterson has stock in IntraBio. The institution of Dr. Patterson has received research support from Glycomine. The institution of Dr. Patterson has received research support from Orphazyme /KemPharm/Zevra. The institution of Dr. Patterson has received research support from Idorsia. The institution of Dr. Patterson has received research support from Shire-Takeda. Dr. Patterson has received publishing royalties from a publication relating to health care. Dr. Patterson has received publishing royalties from a publication relating to health care. |
Terrie Inder | Dr. Inder has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aspect Imaging. Dr. Inder has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. The institution of Dr. Inder has received research support from NIH. Dr. Inder has received publishing royalties from a publication relating to health care. Dr. Inder has received personal compensation in the range of $500-$4,999 for serving as a Study section with NIH. |
Howard P. Goodkin, MD, PhD, FAAN | Dr. Goodkin has received research support from NIH. Dr. Goodkin has received publishing royalties from a publication relating to health care. |
Kevin C. Ess, MD, PhD | Kevin C. Ess, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Betty Law Firm. |
Carsten G. Bonnemann, MD | Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with RYR1 Foundation that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Genethon that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Sarepta Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Kate Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with CureCMD that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Seal Therapeutics that is relevant to AAN interests or activities. |